165 related articles for article (PubMed ID: 12464151)
21. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
[No Abstract] [Full Text] [Related]
22. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
Kouba DJ; Mimouni D; Rencic A; Nousari HC
Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610
[TBL] [Abstract][Full Text] [Related]
24. The first case of sarcoidosis treated with mycophenolate mofetil.
Altschuler EL
Br J Dermatol; 2003 Aug; 149(2):442; discussion 442-3. PubMed ID: 12932272
[No Abstract] [Full Text] [Related]
25. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
Talhari C; Mahnke N; Ruzicka T; Megahed M
Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
[No Abstract] [Full Text] [Related]
27. Mycophenolate mofetil.
Zwerner J; Fiorentino D
Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
[TBL] [Abstract][Full Text] [Related]
28. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
29. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
Zimmerman AB; Berger EM; Elmariah SB; Soter NA
J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Callen JP
Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
[TBL] [Abstract][Full Text] [Related]
31. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
[TBL] [Abstract][Full Text] [Related]
32. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
[TBL] [Abstract][Full Text] [Related]
33. Emerging treatment of atopic dermatitis.
Hsu CJ; Wang LF
Clin Rev Allergy Immunol; 2007 Dec; 33(3):199-203. PubMed ID: 18163226
[TBL] [Abstract][Full Text] [Related]
34. Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.
Nguyen L; McClellan RB; Chaudhuri A; Alexander SR; Chen SF; Concepcion W; Grimm P
Transplantation; 2012 Sep; 94(5):450-5. PubMed ID: 22960763
[TBL] [Abstract][Full Text] [Related]
35. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Wang A; Smith JR; Creevy KE
J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
[TBL] [Abstract][Full Text] [Related]
36. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Mayer DF; Kushwaha SS
Curr Opin Rheumatol; 2003 May; 15(3):219-25. PubMed ID: 12707574
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
Daikeler T
Swiss Med Wkly; 2009 Jan; 139(3-4):34. PubMed ID: 19169900
[No Abstract] [Full Text] [Related]
38. Newer immunosuppressive drugs: a review.
Gummert JF; Ikonen T; Morris RE
J Am Soc Nephrol; 1999 Jun; 10(6):1366-80. PubMed ID: 10361877
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil].
Kono M; Atsumi T
Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2954-9. PubMed ID: 22175137
[No Abstract] [Full Text] [Related]
40. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
